Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | ACHE | P22303 | 6/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15480 | 0.96 | TSHR (0.64) | TSHRTHRBPOLBAPEX1HTT | |
| Potassium SCHEMBL31087662 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL28378579 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| Ammonia Solution, Strong SCHEMBL28569838 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| Water SCHEMBL7119412 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| Hydrochloric Acid SCHEMBL8398425 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL31250004 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| Lithium SCHEMBL31087663 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL28973888 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| 1,4-Butanediol SCHEMBL14910997 | 0.94 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7964683-B2 | Biocompatible polymeric compound, biocompatible polymer and polymer particles | FUJIFILM CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20100016534-A1 | BIOCOMPATIBLE POLYMERIC COMPOUND, BIOCOMPATIBLE POLYMER AND POLYMER PARTICLES | FUJIFILM CORPORATION (JP) | 2010-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100016534-A1 | BIOCOMPATIBLE POLYMERIC COMPOUND, BIOCOMPATIBLE POLYMER AND POLYMER PARTICLES | CD68, ARG1, PUF60 | TSHR 3373/4885THRB 4311/4885POLB 3843/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.